APO RESEARCH · REPORT
Hematopoietic Stem Cells Transplantation
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
Product & engineering
Understand the product.
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
Selected research
Industry Research
Hematopoietic Stem Cells Transplantation Industry Research Report 2026
Market perspective
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
Market competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Top 5 players accounted for about 32.09% market share.
Report Scope
Read the full market overview
This report quantifies the global Hematopoietic Stem Cells Transplantation market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Hematopoietic Stem Cells Transplantation.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hematopoietic Stem Cells Transplantation Market by Company
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis
Hematopoietic Stem Cells Transplantation Segment by Type
Stem Cells Storage
Stem Cells Consumables
Hematopoietic Stem Cells Transplantation Segment by Application
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
Hematopoietic Stem Cells Transplantation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hematopoietic Stem Cells Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hematopoietic Stem Cells Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hematopoietic Stem Cells Transplantation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Hematopoietic Stem Cells Transplantation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cells Storage
- Stem Cells Consumables
Applications
- Leukemia
- Lymphoproliferative Disorders
- Solid Tumors
- Non-Malignant Disorders
Companies covered
- CBR Systems
- China Cord Blood Corporation
- ViaCord
- Thermo Fisher Scientific
- STEMCELL Technologies
- Vcanbio
- Merck Millipore
- Lonza Group
- CellGenix Technologie Transfer
- ThermoGenesis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Hematopoietic Stem Cells Transplantation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Stem Cells Storage
- 2.2.3 Stem Cells Consumables
- 2.3 Hematopoietic Stem Cells Transplantation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Leukemia
- 2.3.3 Lymphoproliferative Disorders
- 2.3.4 Solid Tumors
- 2.3.5 Non-Malignant Disorders
- 2.4 Assumptions and Limitations
3 Hematopoietic Stem Cells Transplantation Breakdown Data by Type
- 3.1 Global Hematopoietic Stem Cells Transplantation Historic Market Size by Type (2021-2026)
- 3.2 Global Hematopoietic Stem Cells Transplantation Forecasted Market Size by Type (2027-2032)
4 Hematopoietic Stem Cells Transplantation Breakdown Data by Application
- 4.1 Global Hematopoietic Stem Cells Transplantation Historic Market Size by Application (2021-2026)
- 4.2 Global Hematopoietic Stem Cells Transplantation Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Hematopoietic Stem Cells Transplantation Market Perspective (2021-2032)
- 5.2 Global Hematopoietic Stem Cells Transplantation Growth Trends by Region
- 5.2.1 Global Hematopoietic Stem Cells Transplantation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Hematopoietic Stem Cells Transplantation Historic Market Size by Region (2021-2026)
- 5.2.3 Hematopoietic Stem Cells Transplantation Forecasted Market Size by Region (2027-2032)
- 5.3 Hematopoietic Stem Cells Transplantation Market Dynamics
- 5.3.1 Hematopoietic Stem Cells Transplantation Industry Trends
- 5.3.2 Hematopoietic Stem Cells Transplantation Market Drivers
- 5.3.3 Hematopoietic Stem Cells Transplantation Market Challenges
- 5.3.4 Hematopoietic Stem Cells Transplantation Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Hematopoietic Stem Cells Transplantation Players by Revenue
- 6.1.1 Global Top Hematopoietic Stem Cells Transplantation Players by Revenue (2021-2026)
- 6.1.2 Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Players (2021-2026)
- 6.2 Global Hematopoietic Stem Cells Transplantation Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Hematopoietic Stem Cells Transplantation Head Office and Area Served
- 6.4 Global Hematopoietic Stem Cells Transplantation Players, Product Type & Application
- 6.5 Global Hematopoietic Stem Cells Transplantation Manufacturers Established Date
- 6.6 Global Hematopoietic Stem Cells Transplantation Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Hematopoietic Stem Cells Transplantation Market Size (2021-2032)
- 7.2 North America Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 7.4 North America Hematopoietic Stem Cells Transplantation Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Hematopoietic Stem Cells Transplantation Market Size (2021-2032)
- 8.2 Europe Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 8.4 Europe Hematopoietic Stem Cells Transplantation Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size (2021-2032)
- 9.2 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Hematopoietic Stem Cells Transplantation Market Size (2021-2032)
- 10.2 South America Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 10.4 South America Hematopoietic Stem Cells Transplantation Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size (2021-2032)
- 11.2 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 CBR Systems
- 12.1.1 CBR Systems Company Information
- 12.1.2 CBR Systems Business Overview
- 12.1.3 CBR Systems Revenue in Hematopoietic Stem Cells Transplantation Business (2021-2026)
- 12.1.4 CBR Systems Hematopoietic Stem Cells Transplantation Product Portfolio
- 12.1.5 CBR Systems Recent Developments
- 12.2 China Cord Blood Corporation
- 12.2.1 China Cord Blood Corporation Company Information
- 12.2.2 China Cord Blood Corporation Business Overview
- 12.2.3 China Cord Blood Corporation Revenue in Hematopoietic Stem Cells Transplantation Business (2021-2026)
- 12.2.4 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Product Portfolio
- 12.2.5 China Cord Blood Corporation Recent Developments
- 12.3 ViaCord
- 12.3.1 ViaCord Company Information
- 12.3.2 ViaCord Business Overview
- 12.3.3 ViaCord Revenue in Hematopoietic Stem Cells Transplantation Business (2021-2026)
- 12.3.4 ViaCord Hematopoietic Stem Cells Transplantation Product Portfolio
- 12.3.5 ViaCord Recent Developments
- 12.4 Thermo Fisher Scientific
- 12.4.1 Thermo Fisher Scientific Company Information
- 12.4.2 Thermo Fisher Scientific Business Overview
- 12.4.3 Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells Transplantation Business (2021-2026)
- 12.4.4 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Product Portfolio
- 12.4.5 Thermo Fisher Scientific Recent Developments
- 12.5 STEMCELL Technologies
- 12.5.1 STEMCELL Technologies Company Information
- 12.5.2 STEMCELL Technologies Business Overview
- 12.5.3 STEMCELL Technologies Revenue in Hematopoietic Stem Cells Transplantation Business (2021-2026)
- 12.5.4 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Product Portfolio
- 12.5.5 STEMCELL Technologies Recent Developments
- 12.6 Vcanbio
- 12.6.1 Vcanbio Company Information
- 12.6.2 Vcanbio Business Overview
- 12.6.3 Vcanbio Revenue in Hematopoietic Stem Cells Transplantation Business (2021-2026)
- 12.6.4 Vcanbio Hematopoietic Stem Cells Transplantation Product Portfolio
- 12.6.5 Vcanbio Recent Developments
- 12.7 Merck Millipore
- 12.7.1 Merck Millipore Company Information
- 12.7.2 Merck Millipore Business Overview
- 12.7.3 Merck Millipore Revenue in Hematopoietic Stem Cells Transplantation Business (2021-2026)
- 12.7.4 Merck Millipore Hematopoietic Stem Cells Transplantation Product Portfolio
- 12.7.5 Merck Millipore Recent Developments
- 12.8 Lonza Group
- 12.8.1 Lonza Group Company Information
- 12.8.2 Lonza Group Business Overview
- 12.8.3 Lonza Group Revenue in Hematopoietic Stem Cells Transplantation Business (2021-2026)
- 12.8.4 Lonza Group Hematopoietic Stem Cells Transplantation Product Portfolio
- 12.8.5 Lonza Group Recent Developments
- 12.9 CellGenix Technologie Transfer
- 12.9.1 CellGenix Technologie Transfer Company Information
- 12.9.2 CellGenix Technologie Transfer Business Overview
- 12.9.3 CellGenix Technologie Transfer Revenue in Hematopoietic Stem Cells Transplantation Business (2021-2026)
- 12.9.4 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Product Portfolio
- 12.9.5 CellGenix Technologie Transfer Recent Developments
- 12.10 ThermoGenesis
- 12.10.1 ThermoGenesis Company Information
- 12.10.2 ThermoGenesis Business Overview
- 12.10.3 ThermoGenesis Revenue in Hematopoietic Stem Cells Transplantation Business (2021-2026)
- 12.10.4 ThermoGenesis Hematopoietic Stem Cells Transplantation Product Portfolio
- 12.10.5 ThermoGenesis Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst